Kalbe Farma Overview

  • Year Founded
  • 1966

Year Founded

  • Status
  • Public

  • Employees
  • 12,806

Employees

  • Stock Symbol
  • KLBF

Stock Symbol

  • Investments
  • 11

  • Share Price
  • $0.04
  • (As of Monday Closing)

Kalbe Farma General Information

Description

PT Kalbe Farma Tbk is engaged in the development, manufacturing, and trading of pharmaceutical products, including human medicines and consumer health products. The company operates four segments: prescription pharmaceuticals, consumer health, Nutritionals, and distribution and logistics. The majority of the company's revenue is derived from the distribution and logistics segments. Its Product and Services are Prescription /Ethicals, Consumer Health, Nutritionals, Distribution & Logistics, Health Services, Medical Devices, and Others.

Contact Information

Website
www.kalbe.co.id
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Gedung Kalbe
  • Jl. Let. Jend. Suprapto Kav. 4
  • Jakarta, 10510
  • Indonesia
+62 (0428)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
IDX
Corporate Office
  • Gedung Kalbe
  • Jl. Let. Jend. Suprapto Kav. 4
  • Jakarta, 10510
  • Indonesia
+62 (0428)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kalbe Farma Stock Performance

As of 16-Nov-2026, Kalbe Farma’s stock price is $0.04. Its current market cap is $1.92B with 45.2B shares.

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.04 $0.04 $0.03 - $0.08 $1.92B 45.2B 61.8M

Kalbe Farma Financials Summary

As of 30-Sep-2026, Kalbe Farma has a trailing 12-month revenue of $2.22B.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 1,683,237 3,142,964 3,762,108 4,757,496
Revenue 2,221,037 2,140,703 2,054,049 1,995,910
EBITDA 300,392 328,335 304,686 283,989
Net Income 218,598 222,103 204,011 181,358
Total Assets 1,854,912 1,834,654 1,799,334 1,732,794
Total Debt 16,345 17,766 34,191 39,612
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Kalbe Farma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Kalbe Farma‘s full profile, request access.

Request a free trial

Kalbe Farma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
PT Kalbe Farma Tbk is engaged in the development, manufacturing, and trading of pharmaceutical products, including human
Drug Discovery
Jakarta, Indonesia
12,806 As of 2026

Jakarta, Indonesia
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Kalbe Farma Competitors (1)

One of Kalbe Farma’s competitors is Kimia Farma (Persero), a Corporate Backed or Acquired company based in Jakarta, Indonesia.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Kimia Farma (Persero) Corporate Backed or Acquired Jakarta, Indonesia
You’re viewing 1 of 1 competitors. Get the full list »

Kalbe Farma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kalbe Farma Investments & Acquisitions (11)

Kalbe Farma’s most recent deal was a Corporate with PROGEN Biotechnik for . The deal was made on 02-Jan-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
PROGEN Biotechnik 02-Jan-2023 Corporate Biotechnology
Global Starway Synergy 06-Dec-2022 Joint Venture Logistics
Sanofi Indonesia 01-Dec-2022 Merger/Acquisition Pharmaceuticals
SL Pogen 01-Jan-2021 Later Stage VC Drug Discovery
Kalgen Innolab 18-Jan-2018 Joint Venture Laboratory Services (Healthcare)
You’re viewing 5 of 11 investments and acquisitions. Get the full list »

Kalbe Farma ESG

Risk Overview

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Kalbe Farma’s complete esg history, request access »

Kalbe Farma Exits (1)

Kalbe Farma’s most recent exit was on 01-Jan-2021 from SL Pogen. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
SL Pogen 01-Jan-2021 Completed
To view Kalbe Farma’s complete exits history, request access »

Kalbe Farma Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Kalbe Consumer Health Jakarta, Indonesia 1956

Kalbe Farma FAQs

  • When was Kalbe Farma founded?

    Kalbe Farma was founded in 1966.

  • Where is Kalbe Farma headquartered?

    Kalbe Farma is headquartered in Jakarta, Indonesia.

  • What is the size of Kalbe Farma?

    Kalbe Farma has 12,806 total employees.

  • What industry is Kalbe Farma in?

    Kalbe Farma’s primary industry is Drug Discovery.

  • Is Kalbe Farma a private or public company?

    Kalbe Farma is a Public company.

  • What is Kalbe Farma’s stock symbol?

    The ticker symbol for Kalbe Farma is KLBF.

  • What is the current stock price of Kalbe Farma?

    As of 16-Nov-2026 the stock price of Kalbe Farma is $0.04.

  • What is the current market cap of Kalbe Farma?

    The current market capitalization of Kalbe Farma is $1.92B.

  • What is Kalbe Farma’s current revenue?

    The trailing twelve month revenue for Kalbe Farma is $2.22B.

  • Who are Kalbe Farma’s competitors?

    Kimia Farma (Persero) is a competitor of Kalbe Farma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process